Cargando…
Testing drug combinations to slow aging
Autores principales: | Ladiges, Warren, Liggitt, Denny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706479/ https://www.ncbi.nlm.nih.gov/pubmed/29291036 http://dx.doi.org/10.1080/20010001.2017.1407203 |
Ejemplares similares
-
Pathology is a critical aspect of preclinical aging studies
por: Ladiges, Warren, et al.
Publicado: (2013) -
Neuropathological assessment and validation of mouse models for Alzheimer's disease: applying NIA-AA guidelines
por: Keene, C. Dirk, et al.
Publicado: (2016) -
The quality control theory of aging
por: Ladiges, Warren
Publicado: (2014) -
The emerging role of geropathology in preclinical aging studies
por: Ladiges, Warren
Publicado: (2017) -
Pathology assessment is necessary to validate translational endpoints in preclinical aging studies
por: Ladiges, Warren
Publicado: (2016)